| Lidocaine Intravenous in the Emergency Department For Sickle Cell Crisis (NCT04614610) | Community Medical Center, Toms River, NJ | 2024-01-01 |
| Flexible Mini Percutaneous Nephrolithotomy Vs Retrograde Intra-renal Surgery (NCT06249100) | Ain Shams University | 2024-01-01 |
| Vaginal Baclofen Suppositories in Chronic Pelvic Pain (NCT05968937) | University of Louisville | 2024-01-01 |
| Study of the Protective Effect of Low-dose Aspirin on Renal Function in Patients With Early Diabetic Nephropathy (NCT06068439) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2024-01-01 |
| Docosahexaenoic Acid (DHA) Supplementation in Amblyopia (NCT03402789) | Johns Hopkins University | 2024-01-01 |
| Trazodone on OSA Endotypes (NCT06286189) | Brigham and Women's Hospital | 2024-01-01 |
| Evaluate the Efficacy, Safety and Tolerability of Fecal Microbiota Transfer for the Treatment of Patients With Nonalcoholic Steatohepatitis (NCT05622526) | Instituto de Investigación Marqués de Valdecilla | 2024-01-01 |
| Study to Evaluate Safety and Efficacy of Rifamycin SV MMX in Treating Traveler's Diarrhea in Children Age 12 to 17 Years (NCT04027894) | RedHill Biopharma Limited | 2024-01-01 |
| Comparison Between Carbapenems and Noncarbapenem Beta-lactam Antibiotics in Septic Burn Patients (NCT07096310) | Ain Shams University | 2024-01-01 |
| Study of A Venetoclax-based, Anthracycline-free Regimen in Newly Diagnosed CBFβ::MYH11(+) AML (NCT06429098) | The First Affiliated Hospital of Soochow University | 2024-01-01 |
| Clinical Study of CAR-T Cell Therapy Following ASCT for R/R B-cell Non-Hodgkin's Lymphoma (NCT06381830) | The First Affiliated Hospital of Soochow University | 2024-01-01 |
| Efficacy and Safety of USL for Dry Eye Disease (NCT06016010) | Chan-Sik Kim | 2024-01-01 |
| Use of Botulinum Toxin A in Direct Eyebrow Lift Scar (NCT06465056) | University of Sao Paulo | 2024-01-01 |
| Cadonilimab in Combination With Bevacizumab and FOLFOX Regimen for the First-Line Treatment of Advanced Unresectable MSS-Type, RAS-Mutated Metastatic Colorectal Cancer (NCT06218810) | Fudan University | 2024-01-01 |
| Clinical Study of Induction Therapy Options Based on Molecular Subtyping and MRD in Children and Adolescents With AML (NCT06221683) | Children's Hospital of Soochow University | 2024-01-01 |
| Cisplatin Plus Temozolomide Compared With Temozolomide in Patients With MGMT Promotor Unmethylated Glioblastoma (NCT06186440) | Zhongnan Hospital | 2024-01-01 |
| Phase 2 Study of CA102N Combined With TAS-102 Compared to Bevacizumab Combined With TAS-102 in Subjects With Relapsed and/or Refractory Metastatic Colorectal Cancer (NCT06039202) | Holy Stone Healthcare Co., Ltd | 2024-01-01 |
| Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial (NCT07167329) | José Claudio Casali da Rocha | 2024-01-01 |
| 177Lu-HTK03170 in mCRPC With PSMA Positive Disease (NCT05570994) | British Columbia Cancer Agency | 2024-01-01 |
| Pediatric-Inspired Chemotherapy Plus Tyrosine Kinase Inhibitor in Adult Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia (NCT04845035) | University of Michigan Rogel Cancer Center | 2024-01-01 |
| Interferon-α for TP53 Myeloid Malignancy Post Allo-HSCT (NCT06130579) | Peking University People's Hospital | 2024-01-01 |
| Efficacy and Safety of MSLN CAR-T in Advanced Malignant Tumors (NCT07399769) | Shenzhen University General Hospital | 2024-01-01 |
| Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) in Healthy Pregnant Women (NCT06997653) | Health Institutes of Turkey | 2024-01-01 |
| Connectivity Changes Associated With Ketamine Assisted Psychotherapy for PTSD (NCT06036511) | University of New Mexico | 2023-12-31 |
| A Study of Efbemalenograstim Alfa Injection for Stage IIIB or IV NSCLC Recieving Moderate-risk Febrile Neutropenia (FN) Chemotherapy Regimen With Risk Factors (NCT06143735) | Tianjin Medical University Cancer Institute and Hospital | 2023-12-31 |
| The Efficacy and Safety of LMV-12 Combined With Osimertinib in NSCLC (NCT06109558) | Hunan Province Tumor Hospital | 2023-12-31 |
| Clinical Trial of TJ271 Injection Combined With Pembrolizumab in the Treatment of Advanced Solid Tumors (NCT05338580) | TJ Biopharma Co., Ltd. | 2023-12-31 |
| To Assess the Efficacy and Safety of Furmonertinib in Patients With Epidermal Growth Factor Receptor 20ins Mutation Positive Stage IB-IIIA Non-small Cell Lung Carcinoma, Following Complete Tumour Resection With or Without Adjuvant Chemotherapy (NCT06192849) | Juan LI, MD | 2023-12-31 |
| HAIC, Lenvatinib, and Cadonilimab as Conversion Therapy for Initially Unresectable Hepatocellular Carcinoma (NCT06187961) | Tongji Hospital | 2023-12-30 |
| Outcome of Combined Botulinum Toxin A Injection and Gastric Balloon Implantation in Obesity Treatment (NCT05872932) | Sebahattin Celik MD | 2023-12-30 |
| Application of Al18F-NOTA-Pentixafor PET/CT for Primary Aldosteronism (NCT06773663) | Peking Union Medical College Hospital | 2023-12-30 |
| Doxorubicin Hydrochloride Liposome Combined With Irinotecan (AI Regimen) Versus VIT Regimen in the Treatment of Relapsed and Refractory Pediatric Rhabdomyosarcoma: a Prospective, Open-label, Randomized Controlled, Multicenter, Phase II Clinical Study (NCT05457829) | Sun Yat-sen University | 2023-12-30 |
| Olive Leaf Extracts in the Control of Hypertension (NCT05636826) | University of Monastir | 2023-12-30 |
| Triggering Oocyte Maturation in Normoresponders Using Double Trigger or HCG Trigger (NCT06146413) | Bedaya Hospital | 2023-12-30 |
| Anticoagulation Using Rivaroxaban on Top of Aspirin in Intracranial Atherosclerotic Stenosis (NCT05700266) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-30 |
| A Randomized, Double-blind, Placebo-controlled Phase II Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetic Profile of Genakumab Injection in Patients With Connective Tissue Disease-associated Interstitial Lung Disease (NCT06189495) | Changchun GeneScience Pharmaceutical Co., Ltd. | 2023-12-30 |
| A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer (NCT06110793) | Memorial Sloan Kettering Cancer Center | 2023-12-29 |
| A Study to Assess BMS-986458 Alone and in Combination With Anti-lymphoma Agents in Relapsed/Refractory Non-Hodgkin Lymphomas (NCT06090539) | Bristol-Myers Squibb | 2023-12-29 |
| The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions (NCT07459790) | JSC NextGen | 2023-12-29 |
| AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia (NCT06137118) | AstraZeneca | 2023-12-29 |
| Safety and Efficacy of SHPL-49 Injection in Participants With Acute Ischemic Stroke (NCT06202378) | Shanghai Hutchison Pharmaceuticals Limited | 2023-12-29 |
| A Stable Glucagon Analog Administered by a Bihormonal Closed Loop System (NCT05454709) | Inreda Diabetic B.V. | 2023-12-29 |
| Non-myeloablative Haploidentical HCT Study for Patients With Sickle Cell Disease, Including Compromised Organ Function (NCT06145282) | National Heart, Lung, and Blood Institute (NHLBI) | 2023-12-28 |
| Anti-CD38 Antibody Treating Pediatric Primary Immune Thrombocytopenia (ITP) (NCT06168851) | Institute of Hematology & Blood Diseases Hospital, China | 2023-12-28 |
| Safety and Efficacy of MSC-EVs in the Prevention of BPD in Extremely Preterm Infants (NCT06279741) | EXO Biologics S.A. | 2023-12-28 |
| A Clinical Study of TQH2722 Injection in the Treatment of Chronic Sinusitis With or Without Nasal Polyps. (NCT06089278) | Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. | 2023-12-28 |
| Phase 2 Trial of BMF-219 in Participants With Type 1 Diabetes Mellitus (NCT06152042) | Biomea Fusion Inc. | 2023-12-28 |
| Exploration of Therapeutic Strategies for NeoRAS Wild-type Metastatic Colorectal Cancer Based on Circulating Tumor DNA (NCT06440902) | Fudan University | 2023-12-28 |
| Potential Benefits of Itopride in the Management of Patients With Metabolic Associated Fatty Liver Disease (MAFLD) (NCT05966025) | October 6 University | 2023-12-28 |
| Phase 2b Trial Comparing HDV-Insulin Lispro to Insulin Lispro in Adults With Type 1 Diabetes Receiving Insulin Degludec (NCT06238778) | Diasome Pharmaceuticals | 2023-12-28 |
| Study of CTO1681 for the Prevention and Treatment of CRS in DLBCL Patients Receiving CAR T-Cell Therapy (NCT05905328) | CytoAgents, Inc. | 2023-12-28 |
| Pimavanserin for Insomnia in Veterans With PTSD (NCT05441280) | VA Office of Research and Development | 2023-12-28 |
| Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer (NCT05997017) | Aadi Bioscience, Inc. | 2023-12-28 |
| Neoadjuvant Treatment of Neuroendocrine Cervix Carcinomar With Camrelizumab Combined With Etoposide and Cisplatin (NCT05910177) | Fujian Cancer Hospital | 2023-12-28 |
| Study of the Research Medicine CIN-103 in Adults With Irritable Bowel Syndrome With Predominant Diarrhea (IBS-D). (NCT06153420) | CinPhloro Pharma, LLC | 2023-12-28 |
| A Study of TCD601 in de Novo Renal Transplant Recipients (NCT05669001) | ITB-Med LLC | 2023-12-28 |
| Chemoablation for Low-Grade Bladder Cancer (NCT07019220) | Ekaterina Laukhtina | 2023-12-27 |
| Adebrelimab Combined With Bevacizumab and Docetaxel for Advanced Non-Squamous Non-small Cell Lung Cancer After Progression on First-line Immunotherapy (NCT06182800) | The First Affiliated Hospital of Xinxiang Medical College | 2023-12-27 |
| A Study to Evaluate JYP0061 Tablets in Patients With Moderate-to-severe Atopic Dermatitis (NCT06158490) | Guangzhou JOYO Pharma Co., Ltd | 2023-12-27 |
| The Efficacy and Safety of Low-dose Radiotherapy Combined With Sintilimab and Temozolomide in Recurrent Glioblastoma (NCT06220552) | Fifth Affiliated Hospital, Sun Yat-Sen University | 2023-12-27 |
| A Study to Evaluate the Efficacy and Safety of VCT220 in Obesity Chinese Population (NCT06569355) | Vincentage Pharma Co., Ltd | 2023-12-27 |
| A Study to Evaluate the Efficacy and Safety of Sutetinib Maleate Capsule in Locally Advanced or Metastatic NSCLC (NCT06010329) | Teligene US | 2023-12-27 |
| Study of APX-115 in Contrast Induced Acute Kidney Injury in Subjects Undergoing PCI (NCT05758896) | Aptabio Therapeutics, Inc. | 2023-12-27 |
| Efficacy of Early Intravenous High-dose Vitamin C in Post-cardiac Arrest Shock. (NCT05817851) | Centre Hospitalier de Bethune | 2023-12-27 |
| Study of Apalutamide With Carotuximab in Metastatic, Castration-Resistant Prostate Cancer (NCT05534646) | Edwin Posadas, MD | 2023-12-27 |
| DMB-I in the Treatment of Alzheimer Type Dementia (NCT06292351) | Bigespas LTD | 2023-12-27 |
| Efficacy and Safety of MK-6194 in Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) (NCT06161116) | Merck Sharp & Dohme LLC | 2023-12-27 |
| Study of Vudalimab or Pembrolizumab in Combination With Chemotherapy as First-line Treatment in Patients With Advanced NSCLC (NCT06173505) | Xencor, Inc. | 2023-12-27 |
| Testing the Safety and Effectiveness of Radiation-based Treatment (Lutetium Lu 177 Dotatate) for Metastatic Prostate Cancer That Has Neuroendocrine Cells (NCT05691465) | National Cancer Institute (NCI) | 2023-12-27 |
| Intestinal Low Dose Radiotherapy Combined With Immunotherapy in Immune-resistant Metastatic Solid Tumors (NCT06076135) | Chuangzhen Chen | 2023-12-26 |
| Study of KTE-X19 in Minimal Residual Disease (MRD) Positive B-Cell Acute Lymphoblastic Leukemia (B-ALL) (NCT06144606) | H. Lee Moffitt Cancer Center and Research Institute | 2023-12-26 |
| A Study of GC012F in Patients With Relapsed/Refractory Multiple Myeloma (NCT06235229) | Gracell Biotechnologies (Shanghai) Co., Ltd. | 2023-12-26 |
| A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in mCRPC Patients (NCT06155084) | Hinova Pharmaceuticals Inc. | 2023-12-26 |
| A Phase Ⅱ Study to Evaluate the Efficacy and Safety of YZJ-4729 in Patients With Moderate to Severe Acute Pain After Abdominal Surgery (NCT06680466) | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | 2023-12-26 |
| A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B (NCT06263959) | Fujian Akeylink Biotechnology Co., Ltd. | 2023-12-26 |
| Chemotherapy-immunotherapy-based Split-course Adaptive Hypofractionated Radiotherapy for Extensive-stage SCLC (NCT06816966) | Fujian Medical University Union Hospital | 2023-12-26 |
| A Study of the Effectiveness and Safety of JS1-1-01 in Patients With Moderate to Severe Depression (NCT06259526) | Tasly Pharmaceutical Group Co., Ltd | 2023-12-26 |
| Using Placental Pathology to Prevent Recurrent Adverse Pregnancy Outcomes: A Pilot Project (NCT06004674) | Endeavor Health | 2023-12-26 |
| Study of Obeldesivir in Children and Adolescents With COVID-19 (NCT05996744) | Gilead Sciences | 2023-12-26 |
| A Study of Participant Reported Preference for Subcutaneous Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) Over Intravenous Pembrolizumab (MK-3475) Formulation in Multiple Tumor Types (MK-3475A-F11) (NCT06099782) | Merck Sharp & Dohme LLC | 2023-12-26 |
| Mesenchymal Stem Cells (MSCs) and Conditioned Medium Mesenchymal Stem Cells as Adjuvant Therapy for Sepsis (NCT07439848) | PT. Prodia Stem Cell Indonesia | 2023-12-25 |
| The Efficacy and Safety of IBI363 in Solid Tumors (NCT06081907) | Hunan Province Tumor Hospital | 2023-12-25 |
| Different Dosing Strategies of Colistin in Multidrug-Resistant Gram-Negative Bacilli Infections (NCT06843668) | Mansoura University | 2023-12-25 |
| Sintilimab in Combination with Cetuximab and Chemotherapy As First-line Treatment for RAS/BRAF Wild-type Advanced Colorectal Cancer (NCT06776757) | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | 2023-12-25 |
| Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer (NCT06186700) | Mansoura University | 2023-12-25 |
| Safety and Efficacy of Anti-FcRL5 CAR-T Cell Therapy in Treating Relapsed and Refractory Multiple Myeloma (R/R MM) (NCT06196255) | Xuzhou Medical University | 2023-12-25 |
| Efficacy and Biomarker Explanation of IBI-323 + Bevacizumab Plus Platinum Based Chemotherapy on ALK-Rearranged NSCLC (NCT05296278) | Hunan Province Tumor Hospital | 2023-12-25 |
| Study of Human Bone Marrow Mesenchymal Stem Cells in APAP (NCT06111846) | Jiuzhitang Maker (Beijing) Cell Technology Co.,Ltd. | 2023-12-25 |
| NALIRIFOX as Induction Therapy in LAPC (NCT06467565) | The First Affiliated Hospital with Nanjing Medical University | 2023-12-25 |
| Perioperative Chemotherapy Combined With Serplulimab or Placebo for pMMR Locally Advanced Gastric Adenocarcinoma (FOCUS-05) (NCT05872685) | Yu jiren | 2023-12-24 |
| Multimodal Vasopressor Strategy in Septic Shock (NCT06155812) | University Medical Centre Maribor | 2023-12-23 |
| Evaluate the Efficacy and Safety of SHR-1918 in Patients With Homozygous Familial Hypercholesterolemia (NCT06009393) | Beijing Suncadia Pharmaceuticals Co., Ltd | 2023-12-22 |
| Study of Tamibarotene in Patients With ADPKD (NCT06289998) | Rege Nephro Co., Ltd. | 2023-12-22 |
| Study of CM310 in Children Subjects With Moderate-to-severe Atopic Dermatis (NCT06162507) | Keymed Biosciences Co.Ltd | 2023-12-22 |
| Trial Of Stereotactic Body Radiation Therapy (SBRT) for Oligoprogression on Immune Checkpoint Inhibitors (ICI) in Metastatic Renal Cell Carcinoma (NCT04974671) | Yale University | 2023-12-22 |
| Glucagon Enhanced Insulin Absorption in Diabetes Mellitus Type 1 (NCT05960565) | St. Olavs Hospital | 2023-12-22 |
| A Study of SHR2554 With Chemotherapy in Treatment-naïve Patients With Peripheral T-cell Lymphoma (NCT06173999) | Jiangsu HengRui Medicine Co., Ltd. | 2023-12-22 |
| Dose-finding Study of MR-130A-01 Contraceptive Transdermal Patch (NCT06048536) | Mylan Pharmaceuticals Inc | 2023-12-22 |
| Phase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate Cancer (NCT06139575) | Bivision Pharmaceuticals, Inc. | 2023-12-22 |
| Using Mirabegron to Increase BP in Patients With POTS (NCT06133075) | Cedars-Sinai Medical Center | 2023-12-22 |